Private healthcare costs and regulatory challenges in India's health sector

Updated 29 Aug 2026

Contents4

The Hindu - Opinion · 29 Aug 2026 · 2 min read
Prelims · Health Mains · GS2 Governance High relevance

The Parliamentary Standing Committee on Health highlighted the high cost disparity between private and public healthcare, recommending price regulation and cross-subsidization, while balancing the need for private investment in healthcare infrastructure.

Key points

Cost Disparity: The average cost of hospitalization in private facilities is ₹50,508 compared to ₹6,631 in government facilities, highlighting the financial burden on families.

Parliamentary Recommendations: The committee proposed 368 measures, including standardised package rates and pre-treatment cost estimates to enhance transparency.

Cross-Subsidization: Large corporate hospitals are urged to reserve beds for AB-PMJAY beneficiaries and cross-subsidize poorer patients, addressing affordability issues.

FDI in Healthcare: The report calls for a review of FDI rules in hospital acquisitions, balancing investment needs with concerns over aggressive corporatization and rising costs.

Information Asymmetry: Patients often lack the knowledge to evaluate treatment necessity, leading to potential over-treatment driven by financial incentives in private healthcare.

Private Equity Influence: Corporate hospitals' focus on high-revenue procedures and premium infrastructure can inflate costs, necessitating regulatory safeguards.

[GS3-Economy] The health sector's reliance on private investment underscores the need for policies that ensure equitable access without deterring capital inflow.

Medicalisation: Overuse of diagnostics and procedures, such as unnecessary Caesarean sections, reflects systemic incentives rather than clinical need.

Way Forward: India should enforce price transparency, mandate affordable bed quotas in private hospitals, and incentivize greenfield investments in underserved areas to balance affordability and quality.

Key terms

AB-PMJAY
Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana is a flagship health insurance scheme providing ₹5 lakh coverage per family annually for secondary and tertiary care. It aims to reduce out-of-pocket expenses for vulnerable populations, aligning with SDG 3.8 on universal health coverage.
Information Asymmetry
A market condition where providers possess more knowledge than patients, leading to potential exploitation. In healthcare, this can result in unnecessary treatments, emphasizing the need for regulatory frameworks to protect patient interests.
Cross-Subsidization
A financial model where profits from high-end services subsidize costs for economically weaker sections. This is critical for equitable healthcare access but requires strict enforcement to prevent bypassing of obligations by private hospitals.
FDI in Healthcare
Foreign Direct Investment in India's healthcare sector is permitted up to 100% under the automatic route. While it brings capital and expertise, unchecked acquisitions can lead to market consolidation and inflated prices, necessitating balanced policy oversight.

Practice question

Critically examine the challenges and regulatory measures needed to address the cost disparity between private and public healthcare in India. (250 words, 15 marks)

GS2 15 marks 250 words Mains

Key terms to include: AB-PMJAY FDI in Healthcare Information Asymmetry Cross-Subsidization SDG 3.8 Private Equity Corporate Hospitals Regulatory Frameworks

Answer framework

Introduction

Briefly introduce the context of India's healthcare system, highlighting the significant cost disparity between private and public healthcare facilities and its impact on affordability and access.

Challenges in Private Healthcare

High cost of hospitalization in private facilities compared to public ones, leading to financial burden on families.

Information asymmetry where patients lack knowledge to evaluate treatment necessity, leading to potential over-treatment.

Influence of private equity and corporate hospitals focusing on high-revenue procedures, inflating costs.

Regulatory Measures Proposed

Standardised package rates and pre-treatment cost estimates to enhance transparency.

Cross-subsidization model where large corporate hospitals reserve beds for AB-PMJAY beneficiaries.

Review of FDI rules in hospital acquisitions to balance investment needs with concerns over aggressive corporatization.

Way Forward

Enforce price transparency and mandate affordable bed quotas in private hospitals.

Incentivize greenfield investments in underserved areas to balance affordability and quality.

Strengthen regulatory frameworks to protect patient interests and ensure equitable access to healthcare.

Conclusion

Emphasize the need for a balanced approach that ensures equitable access to healthcare without deterring private investment, aligning with SDG 3.8 on universal health coverage.

Fact check

All facts verified